Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
作者信息
Cyrenne B M, Al-Mohammedi F, DeKoven J G, Alhusayen R
机构信息
Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
出版信息
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e546-e548. doi: 10.1111/jdv.17342. Epub 2021 May 29.
Abstract
摘要
相似文献
1
Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e546-e548. doi: 10.1111/jdv.17342. Epub 2021 May 29.
2
Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
J Dtsch Dermatol Ges. 2022 Aug;20(8):1123-1124. doi: 10.1111/ddg.14784. Epub 2022 Jun 14.
3
Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Cutis. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411.
4
Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
J Formos Med Assoc. 2022 May;121(5):1003-1007. doi: 10.1016/j.jfma.2021.12.028. Epub 2022 Jan 5.
5
Pityriasis rosea after mRNA COVID-19 vaccination.
Int J Dermatol. 2021 Sep;60(9):1150-1151. doi: 10.1111/ijd.15700. Epub 2021 Jun 10.
6
Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4097-4098. doi: 10.1080/21645515.2021.1963173. Epub 2021 Aug 26.
7
Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination.
Br J Dermatol. 2021 Aug;185(2):e34. doi: 10.1111/bjd.20143. Epub 2021 Apr 26.
8
The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
Dermatol Ther. 2022 Aug;35(8):e15601. doi: 10.1111/dth.15601. Epub 2022 Jun 13.
9
Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
J Cosmet Dermatol. 2023 Sep;22(9):2380-2381. doi: 10.1111/jocd.15755. Epub 2023 Jun 29.
10
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.
引用本文的文献
1
A Cross-Sectional Study of Epidemiological and Clinical Aspects of Pityriasis Rosea along with Dermoscopic Analysis and Histopathology Correlation.
Indian J Dermatol. 2024 Mar-Apr;69(2):145-151. doi: 10.4103/ijd.ijd_1071_23. Epub 2024 Apr 29.
2
Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.
Cureus. 2024 Mar 17;16(3):e56310. doi: 10.7759/cureus.56310. eCollection 2024 Mar.
3
Pityriasis following COVID-19 vaccinations: a systematic review.
Dermatol Reports. 2023 Aug 9;16(1):9742. doi: 10.4081/dr.2023.9742. eCollection 2024 Mar 12.
4
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
Clin Cosmet Investig Dermatol. 2024 Jan 8;17:51-57. doi: 10.2147/CCID.S447834. eCollection 2024.
5
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
6
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
7
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
8
Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
Immun Inflamm Dis. 2023 Apr;11(4):e804. doi: 10.1002/iid3.804.
9
Histopathological Spectrum of Cutaneous Reactions following COVID-19 Vaccine - An Observational Study.
Indian Dermatol Online J. 2023 Mar 3;14(2):207-212. doi: 10.4103/idoj.idoj_449_22. eCollection 2023 Mar-Apr.
10
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
Dermatol Reports. 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. eCollection 2023 Mar 7.
本文引用的文献
1
SARS-CoV-2 spike protein positivity in pityriasis rosea-like and urticaria-like rashes of COVID-19.
Br J Dermatol. 2021 Jun;184(6):1194-1195. doi: 10.1111/bjd.19833. Epub 2021 Mar 4.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases.
JAAD Case Rep. 2021 Jan;7:93-94. doi: 10.1016/j.jdcr.2020.10.035. Epub 2020 Nov 7.
4
Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.
J Med Virol. 2021 Apr;93(4):1850-1851. doi: 10.1002/jmv.26549. Epub 2020 Oct 7.
5
SARS-CoV-2 as possible inducer of viral reactivations.
Dermatol Ther. 2020 Nov;33(6):e13878. doi: 10.1111/dth.13878. Epub 2020 Jul 6.
6
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
Br J Dermatol. 2020 Sep;183(3):431-442. doi: 10.1111/bjd.19264. Epub 2020 Jul 5.
7
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.
8
Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
J Eur Acad Dermatol Venereol. 2016 Mar;30(3):544-5. doi: 10.1111/jdv.12942. Epub 2014 Dec 29.
9
An atypical case of pityriasis rosea gigantea after influenza vaccination.
Case Rep Dermatol. 2014 Apr 18;6(1):119-23. doi: 10.1159/000362640. eCollection 2014 Jan.
10
Pityriasis rosea following influenza (H1N1) vaccination.
J Chin Med Assoc. 2011 Jun;74(6):280-2. doi: 10.1016/j.jcma.2011.04.010. Epub 2011 May 12.
Zotero 插件